Castle Biosciences, Inc. (NASDAQ: CSTL)
$26.8000
+0.3000 ( +1.17% ) 96.6K
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
Market Data
Open
$26.8000
Previous close
$26.5000
Volume
96.6K
Market cap
$742.19M
Day range
$25.7420 - $27.0440
52 week range
$16.9650 - $35.8400
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Dec 05, 2024 |
| 4 | Insider transactions | 1 | Nov 19, 2024 |
| 4 | Insider transactions | 1 | Nov 14, 2024 |
| 4 | Insider transactions | 1 | Nov 07, 2024 |
| 4 | Insider transactions | 1 | Nov 06, 2024 |
| 4 | Insider transactions | 1 | Nov 05, 2024 |
| 4 | Insider transactions | 1 | Nov 05, 2024 |
| 8-k | 8K-related | 69 | Nov 04, 2024 |
| 10-q | Quarterly Reports | 77 | Nov 04, 2024 |
| 4 | Insider transactions | 1 | Oct 16, 2024 |